Several studies have linked SHROOM2 to the risk and pathogenesis of esophageal squamous carcinoma, colorectal cancer, and medulloblastoma (Closa et al., 2014; Liu et al., 2024; Shou et al., 2015). This evidence concerns the gene SHROOM2 and colorectal cancer.